{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:38:42Z","timestamp":1758634722848,"version":"3.32.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.plefa.2006.02.006","type":"journal-article","created":{"date-parts":[[2006,4,18]],"date-time":"2006-04-18T19:19:35Z","timestamp":1145387975000},"page":"317-321","source":"Crossref","is-referenced-by-count":23,"title":["Cyclooxygenase inhibitors not inhibit resting lung cancer A549 cell proliferation"],"prefix":"10.1016","volume":"74","author":[{"given":"Weigang","family":"Duan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16 Pt 1","key":"10.1016\/j.plefa.2006.02.006_bib1","first-page":"5835","article-title":"Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers","volume":"9","author":"Mao","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.plefa.2006.02.006_bib2","article-title":"Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors","author":"Shaik","year":"2005","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.plefa.2006.02.006_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF02885407","article-title":"The effects of nimesulide combined with cisplatin on lung cancer","volume":"24","author":"Xing","year":"2004","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"issue":"2","key":"10.1016\/j.plefa.2006.02.006_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/sj.bjp.0703573","article-title":"Investigation into the involvement of phospholipases A(2) and MAP kinases in modulation of AA release and cell growth in A549 cells","volume":"131","author":"Choudhury","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.plefa.2006.02.006_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2249.2005.02739.x","article-title":"4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a component of tobacco smoke, modulates mediator release from human bronchial and alveolar epithelial cells","volume":"140","author":"Proulx","year":"2005","journal-title":"Clin. Exp. Immunol."},{"issue":"14","key":"10.1016\/j.plefa.2006.02.006_bib6","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1096\/fj.03-0329fje","article-title":"IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB\/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis","volume":"17","author":"Jung","year":"2003","journal-title":"FASEB J."},{"issue":"1\u20132","key":"10.1016\/j.plefa.2006.02.006_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0303-7207(03)00091-1","article-title":"Inhibition of IL-1beta-dependent prostaglandin E2 release by antisense microsomal prostaglandin E synthase 1 oligonucleotides in A549 cells","volume":"205","author":"Sweeney","year":"2003","journal-title":"Mol. Cell Endocrinol."},{"issue":"6","key":"10.1016\/j.plefa.2006.02.006_bib8","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/sj.bjp.0703431","article-title":"The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes","volume":"130","author":"Newton","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.plefa.2006.02.006_bib9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.jtcvs.2004.12.048","article-title":"Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung cancer for dose-dependent effect","volume":"129","author":"Sievers","year":"2005","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"24","key":"10.1016\/j.plefa.2006.02.006_bib10","doi-asserted-by":"crossref","first-page":"8641","DOI":"10.1158\/1078-0432.CCR-04-1435","article-title":"Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance","volume":"10","author":"Singh","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.plefa.2006.02.006_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1465-9921-6-27","article-title":"Atorvastatin reduces lipopolysaccharide-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells","volume":"6","author":"Wu","year":"2005","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.plefa.2006.02.006_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.bjp.0703612","article-title":"Oncostatin M synergises with house dust mite proteases to induce the production of PGE(2) from cultured lung epithelial cells","volume":"131","author":"Knight","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.plefa.2006.02.006_bib13","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.4049\/jimmunol.163.6.3459","article-title":"A novel mechanism of action of chemically modified tetracyclines: inhibition of COX-2-mediated prostaglandin E2 production","volume":"163","author":"Patel","year":"1999","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.plefa.2006.02.006_bib14","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/sj.bjp.0701283","article-title":"Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide","volume":"121","author":"Watkins","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.plefa.2006.02.006_bib15","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1476-5381.1994.tb17093.x","article-title":"Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone","volume":"113","author":"Mitchell","year":"1994","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.plefa.2006.02.006_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cellsig.2004.07.008","article-title":"Phorbol 12-myristate 13-acetate upregulates cyclooxygenase-2 expression in human pulmonary epithelial cells via Ras, Raf-1, ERK, and NF-kappaB, but not p38 MAPK, pathways","volume":"17","author":"Chang","year":"2005","journal-title":"Cell Signal"},{"issue":"1\u20133","key":"10.1016\/j.plefa.2006.02.006_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-5793(03)00672-0","article-title":"IL-1beta-dependent activation of NF-kappaB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase","volume":"547","author":"Catley","year":"2003","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.plefa.2006.02.006_bib18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1248\/yakushi.125.587","article-title":"Antiatherogenic effects of Phyllanthus Emblica associated with Corilagin and its Analogue","volume":"5","author":"Duan","year":"2005","journal-title":"Yakugaku Zasshi"},{"issue":"1 Pt 1","key":"10.1016\/j.plefa.2006.02.006_bib19","first-page":"L126","article-title":"Prostaglandin G\/H synthase-2 is the constitutive and dominant isoform in cultured human lung epithelial cells","volume":"271","author":"Asano","year":"1996","journal-title":"Am. J. Physiol."},{"issue":"6","key":"10.1016\/j.plefa.2006.02.006_bib20","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1124\/mol.58.6.1398","article-title":"Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells","volume":"58","author":"Hung","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.plefa.2006.02.006_bib21","first-page":"303","article-title":"Expression of cyclooxygenase 2 in human malignant melanoma","volume":"61","author":"Denkert","year":"2001","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.plefa.2006.02.006_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-3565(24)39262-6","article-title":"Inhibition of cyclooxygenase-2 decreases DNA synthesis induced by platelet-derived growth factor in Swiss 3T3 fibroblasts","volume":"293","author":"Castano","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.plefa.2006.02.006_bib23","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1194\/jlr.M300455-JLR200","article-title":"Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells","volume":"45","author":"Yang","year":"2004","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.plefa.2006.02.006_bib24","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1073\/pnas.0334211100","article-title":"Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion","volume":"100","author":"Bagga","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"17","key":"10.1016\/j.plefa.2006.02.006_bib25","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1016\/j.febslet.2005.06.004","article-title":"Peroxisome proliferator-activated receptor delta as a molecular target to regulate lung cancer cell growth","volume":"579","author":"Fukumoto","year":"2005","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.plefa.2006.02.006_bib26","first-page":"493","article-title":"The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines","volume":"25","author":"Morosetti","year":"2004","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.plefa.2006.02.006_bib27","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1158\/0008-5472.CAN-04-3441","article-title":"Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition","volume":"65","author":"Avis","year":"2005","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.plefa.2006.02.006_bib28","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4049\/jimmunol.165.3.1605","article-title":"Differential Regulation of Prostaglandin E2 and Thromboxane A2 Production in Human Monocytes: implications for the use of cyclooxygenase inhibitors","volume":"165","author":"Peter","year":"2000","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.plefa.2006.02.006_bib29","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3748\/wjg.v11.i8.1228","article-title":"Relationship between expression and distribution of cyclooxygenase-2 and bcl-2 in human gastric adenocarcinoma","volume":"11","author":"Chen","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.plefa.2006.02.006_bib30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fertnstert.2004.06.057","article-title":"Distribution of cyclooxygenase-1, cyclooxygenase-2, and cytosolic phospholipase A2 in the luteal phase human endometrium and ovary","volume":"83","author":"Stavreus-Evers","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.plefa.2006.02.006_bib31","doi-asserted-by":"crossref","first-page":"F1173","DOI":"10.1152\/ajprenal.0116.2001","article-title":"Urogenital distribution of a mouse membrane-associated prostaglandin E2 synthase","volume":"281","author":"Guan","year":"2001","journal-title":"Am. J. Physiol. Renal. Physiol."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327806000287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327806000287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T12:54:42Z","timestamp":1736340882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327806000287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0952327806000287"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2006.02.006","relation":{},"ISSN":["0952-3278"],"issn-type":[{"type":"print","value":"0952-3278"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}